APA

Yokoyama M., Terui Y., Takeuchi K., Nara E., Nakano K., Ueda K., Nishimura N., Mishima Y., Sakajiri S., Tsuyama N., Ozawa K. & Hatake K. (20130522). Infusion Rate Escalation Study of Rituximab in Patients with CD20+ B-Cell Lymphomas: A Single Institution Analysis in Japan. : ISRN oncology.

Chicago

Yokoyama Masahiro, Terui Yasuhito, Takeuchi Kengo, Nara Eriko, Nakano Kenji, Ueda Kyoko, Nishimura Noriko, Mishima Yuko, Sakajiri Sakura, Tsuyama Naoko, Ozawa Keiya and Hatake Kiyohiko. 20130522. Infusion Rate Escalation Study of Rituximab in Patients with CD20+ B-Cell Lymphomas: A Single Institution Analysis in Japan. : ISRN oncology.

Harvard

Yokoyama M., Terui Y., Takeuchi K., Nara E., Nakano K., Ueda K., Nishimura N., Mishima Y., Sakajiri S., Tsuyama N., Ozawa K. and Hatake K. (20130522). Infusion Rate Escalation Study of Rituximab in Patients with CD20+ B-Cell Lymphomas: A Single Institution Analysis in Japan. : ISRN oncology.

MLA

Yokoyama Masahiro, Terui Yasuhito, Takeuchi Kengo, Nara Eriko, Nakano Kenji, Ueda Kyoko, Nishimura Noriko, Mishima Yuko, Sakajiri Sakura, Tsuyama Naoko, Ozawa Keiya and Hatake Kiyohiko. Infusion Rate Escalation Study of Rituximab in Patients with CD20+ B-Cell Lymphomas: A Single Institution Analysis in Japan. : ISRN oncology. 20130522.